Results 221 to 230 of about 4,877,471 (249)

Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system

Drugs in Context, 2019
Vincenzo Accurso, Marco Santoro, Salvatrice Mancuso, Marisante Napolitano , Florinda Di Piazza, Antonio Russo, Sergio Mario Siragusa   +6 more
doaj   +1 more source

The International Prognostic Scoring System does not accurately discriminate different risk categories in patients with post-essential thrombocythemia and post-polycythemia vera myelofibrosis [PDF]

Boque, Concepción, Gómez, Montse, Hernández Boluda, Juan Carlos, Luño Fernández, Elisa, Pereira, Arturo   +4 more
core   +1 more source

Treatment of primary myelofibrosis

Turkish Journal of Hematology, 2009
Şinasi Özsoylu
doaj  

Cerebral venous sinus thrombosis associated with JAK2 V617F mutation-related pre-primary myelofibrosis: a case report and literature review. [PDF]

BMC Neurol
Song J, Huang C, Jia L, Wang M, Wu C, Ji X, Song H, Meng R, Zhou D.   +8 more
europepmc   +1 more source

Circulating Polymorphonuclear Myeloid-Derived Suppressor Cells (PMN-MDSCs) Have a Biological Role in Patients with Primary Myelofibrosis. [PDF]

Cancers (Basel)
Campanelli R, Carolei A, Catarsi P, Abbà C, Boveri E, Paulli M, Gentile R, Morosini M, Albertini R, Mantovani S, Massa M, Barosi G, Rosti V.   +12 more
europepmc   +1 more source

Significance of cytogenetic-risk categories and refined international prognostic scoring system for overall survival in primary myelofibrosis: A single-center experience

, 2018
Vesna Djordjević, Marija Denčić‐Fekete, Jelica Jovanović, Ivan Soldatović, Gradimir Janković, Andrija Bogdanović   +5 more
openalex   +2 more sources

Advances in Molecular Understanding of Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis: Towards Precision Medicine. [PDF]

Cancers (Basel)
Tashkandi H, Younes IE.
europepmc   +1 more source